ClinicalTrials.gg
WithdrawnNCT04703517Updated Jul 20, 2026

Musculoskeletal Ultrasound for Diagnosis of Shoulder Dislocation Reduction

An interventional study of Point of care ultrasound in Ultrasound, Shoulder Dislocation and Musculoskeletal Injury, sponsored by Rutgers, The State University of New Jersey. Withdrawn. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-20.

Sponsored by Rutgers, The State University of New Jersey · Not applicable, Interventional, and Diagnostic

Why this study was withdrawn
The study was never approved by the IRB
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This study will compare the current standard of care post reduction plain film x ray for confirmation of shoulder reduction to point of care ultrasound. Patients will receive both the current standard of care post reduction x ray and point of care ultrasound to act as their own comparators

02

Conditions studied

  • Ultrasound
  • Shoulder Dislocation
  • Musculoskeletal Injury

Browse trials for

03

In context

Shoulder Dislocation

105 studies on the registry are indexed under Shoulder Dislocation; 22 are open to participants now.

Browse Shoulder Dislocation studies →

Lead sponsor

Rutgers, The State University of New Jersey is the lead sponsor of 506 studies on the registry; 131 are open to participants now.

Of its 39 completed or terminated interventional studies of FDA-regulated products, 31 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults greater than or equal to 18 years
  • Acute shoulder dislocation

Exclusion criteria

Exclusion Criteria:

  • Associated fracture
  • Associated neurovascular injury
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Other
    Self Controlled

    Patients will active as their own comparator

    Diagnostic Test: Point of care ultrasound

Interventions

  • Diagnostic testPoint of care ultrasound

    Patients will receive a point of care ultrasound at the bedside in the Emergency Department and compare the impression to the x ray result

06

What researchers measure

Primary outcomes

  1. Comparison of X ray to Ultrasound for Shoulder Reduction

    Compare the impression of the x ray to the ultrasound for successful shoulder reduction

    Time frame: through study completion up to 1 year

Secondary outcomes

  1. Comparison of X ray to Ultrasound in the diagnosis of post shoulder reduction complications

    Compare the impression of the x ray to the ultrasound for shoulder dislocation complications

    Time frame: through study completion up to 1 year

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04703517
Responsible party
Human Research Protection Program (PRS Admin on behalf of Jesper Aurup MD, Assistant Professor, Rutgers, The State University of New Jersey) — Principal investigator
First posted
Jan 11, 2021
Start date
Jan 1, 2021
Primary completion
Dec 30, 2021
Completion
Dec 30, 2021
Last update
Jul 20, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion